UNSPSC 85891820: Low dose rate (ldr) brachytherapy of pituitary gland using californium 252 (cf-252)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of low dose rate (ldr) brachytherapy of pituitary gland using californium 252 (cf-252). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code DG10BCZ

UNSPSC 85891820 Low dose rate (ldr) brachytherapy of pituitary gland using californium 252 (cf-252) is a Commodity code that shows no relevant recent state and local procurement activity. The single opportunity posted under this code—Santa Clara County Health System's temporary health professional staffing services RFQ (RFSQHHSFY270052, due October 7, 2026)—addresses ancillary clinical staffing across audiology, cardiology, diagnostic imaging, gastroenterology, orthopedic, respiratory care, surgical services, and therapy categories, which falls outside the narrowly defined scope of specialized brachytherapy treatment using californium-252. The mismatch suggests either a coding error in the state or local procurement office's tagging or a data artifact; the code's nominal scope—a specific radiotherapy modality for pituitary pathology—does not align with general temporary clinical staffing procurement.

No representative opportunities for the code's actual scope are present in the recent solicitation record. State and local buyers do not appear to be actively soliciting brachytherapy services or related radiotherapy equipment and supplies under this Commodity designation at this time. Firms pursuing work in this clinical specialty should monitor state health department and major teaching hospital procurement channels directly rather than expect regular activity under this code designation.